First post-mortal transplantation of both lungs in Ukraine
pdf (Українська)

Keywords

lung transplantation, immunosuppression, quality of life

How to Cite

Samchuk , O., & Matolinets , N. (2022). First post-mortal transplantation of both lungs in Ukraine. The Practitioner, (4), 71-76. Retrieved from https://plr.com.ua/index.php/journal/article/view/742

Abstract

Lung transplantation is a method of treatment of terminal stages of chronic lung diseases accepted by all world standards, because its results can increase the duration and improve the quality of life of this cohort of patients. Despite this, this method was not available in Ukraine. However, with the recent development of the Ukrainian school of transplantology, there are opportunities for the introduction and use of this method in clinical practice. The paper presents the analysis of the first in Ukraine case of lung transplantation in the Lviv Clinical Emergency Hospital. Lung transplantation is a long process that requires multi-component treatment and supervision of qualified personnel at all stages of medical care. In the postoperative period, it is necessary to constantly monitor vital signs and indicators of laboratory and instrumental examinations in order to detect early complications. In the treatment of these patients a special role belongs to the rational appointment of antibiotics in the scheme of multicomponent therapy, in order to prevent infectious complications that may develop on the background of immunosuppression. After competent lung transplantation and subsequent postoperative treatment, patients report an improvement in general wellbeing, increased physical and mental activity, which generally contributes to improving the quality of life.

pdf (Українська)

References

1. Valapour M, Skeans MA, Smith JM, Edwards LB, Cherikh WS, Uccellini K et al. OPTN/SRTR 2015 Annual Data Report: Lung. Am J Transplant. 2017;17(1):357-424. doi: 10.1111/ajt.14129.
2. Hardy JD, Webb WR, Dalton ML, Walker GR. Lung homotransplantation in man. JAMA. 1963 Dec 21;186:1065-74. doi:10.1001/jama.1963.63710120001010.
3. Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017 Oct; 36(10):1047-1059. doi:10.1016/j.healun.2017.07.016. Epub 2017 Jul 19.
4. David W. Lung transplantation: indications and contraindications. J Thorac Dis. 2018 Jul; 10(7):4574-4587. doi: 10.21037/jtd.2018.06.141.
5. Fisher A, Andreasson A, Chrysos A, Lally J, Mamasoula V, Exley C et al. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK. Health Technol Assess. 2016;20(85). doi: 10.3310/hta20850.
6. Maria-Jose S, David F, Katherine J, Justin W, Dale L. Improvement in health-related quality of life after lung transplantation. Can Respir J. 2009 Sep- Oct; 16(5):153-8. doi: 10.1155/2009/843215.
7. Thabut G, Mal H. Outcomes after lung transplantation. J Thorac Dis. 2017 Aug; 9(8):2684-2691. doi: 10.21037/jtd.2017.07.855.
8. Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant. 2009 Jul; 9(7):1640-9. doi: 10.1111/j.1600-6143.2009.02613.x.

Downloads

Download data is not yet available.